indications
Last reviewed 01/2018
- systemic treatment of varicella-zoster infection
- systemic and topical treatment of herpes simplex infections of skin, mucous membranes and eye
- prevention of recurrence of varicella-zoster and herpes simplex infections
- Epstein-Barr virus is only inhibited at very high levels; cytomegalovirus proliferation is uninfluenced at clinically attainable concentrations